NSD1 and neoplasm: Collectively these results demonstrate that silencing Wnt10b in combination with NSD1 knockout imposes a significant blockade in the Wnt/β-catenin signaling pathway, and thereby strongly inhibits tumor formation as well as extent of metastatic lesions in vivo.